A news item announcing a clinical research update on a new preventative therapy for chemotherapy-related nerve damage, useful for readers tracking drug development and translational neurology.
Key Takeaways
- We are open to conversations with prospective partners and investors who share our vision
- First-in-class neuroprotective candidate being developed to prevent chemotherapy-induced peripheral neuropathy
- Notes that no approved preventive therapies currently exist